T. Rowe Price Investment Management, Inc.

Holdings History for Ascendis Pharma A/S - Common Stock (ASND)

Symbol: ASND on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Shares Owned: 2,667,563 shares
Security Ownership %: 4.8%

Shares, Excluding Options vs Price

Value, Excluding Options

T. Rowe Price Investment Management, Inc. ownership in Ascendis Pharma A/S Common Stock (ASND)

14 Nov 2025 - T. Rowe Price Investment Management, Inc. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,667,563 shares of Ascendis Pharma A/S Common Stock (ASND). This represents 4.8% ownership of the company. In their previous filing dated 14 Aug 2025, T. Rowe Price Investment Management, Inc. had reported owning 3,583,546 shares, indicating a decrease of +26%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
T. Rowe Price Investment Management, Inc.	4.8%	-27%	$530,338,200	2,667,563	-915,983	-26%	$198.81	13G/A	30 Sep 2025	14 Nov 2025, 12:18
T. Rowe Price Investment Management, Inc.	6.4%	+28%	$632,460,034	3,583,546	+529,722	+17%	$176.49	13G/A	30 Jun 2025	14 Aug 2025, 12:12
T. Rowe Price Investment Management, Inc.	5%		$489,986,061	3,053,824			$160.45	13G	31 Mar 2025	14 May 2025, 10:47

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.22%	-0.23%	$355,605,000	1,667,625	-998,993	-37%	$213.24	Q4 2025
30 Sep 2025	0.32%	-0.11%	$530,151,000	2,666,618	-916,928	-26%	$198.81	Q3 2025
30 Jun 2025	0.39%	+0.06%	$618,521,000	3,583,546	+529,722	+17%	$172.60	Q2 2025
31 Mar 2025	0.31%	+0.03%	$475,970,000	3,053,824	+328,278		$155.86	Q1 2025
31 Dec 2024	0.23%	+0.08%	$375,226,000	2,725,546	+960,504	+54%	$137.67	Q4 2024
30 Sep 2024	0.16%	+0.16%	$263,539,000	1,765,042	+1,734,478	+5675%	$149.31	Q3 2024
30 Jun 2024	0%	-0.21%	$4,169,000	30,564	-2,538,339	-99%	$136.40	Q2 2024
31 Mar 2024	0.24%	-0.13%	$388,342,000	2,568,903	-1,420,927	-36%	$151.17	Q1 2024
31 Dec 2023	0.33%	+0%	$502,520,000	3,989,830	+5,327	+0.13%	$125.95	Q4 2023
30 Sep 2023	0.26%	+0%	$373,109,000	3,984,503	+1,610	+0.04%	$93.64	Q3 2023
30 Jun 2023	0.24%	+0.03%	$355,474,000	3,982,893	+509,427	+15%	$89.25	Q2 2023
31 Mar 2023	0.27%	+0.05%	$372,426,000	3,473,466	+645,199	+23%	$107.22	Q1 2023
31 Dec 2022	0.27%	+0.08%	$345,417,000	2,828,267	+796,087	+39%	$122.13	Q4 2022
30 Sep 2022	0.17%	0%	$209,843,000	2,032,180	0		$103.26	Q3 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.